Biosolution Co.Ltd (086820) — Cash Flow Reinvestment Rate
Biosolution Co.Ltd (086820) has a Cash Flow Reinvestment Rate of 2.23x as of September 2025, reinvesting ₩38.75 Million (capex ₩22.15 Million plus investments ₩16.60 Million) from operating cash flow of ₩17.41 Million. Check 086820 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biosolution Co.Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Biosolution Co.Ltd across 3 annual periods. Explore how much of Biosolution Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Biosolution Co.Ltd (2018–2023)
Year-by-year capital reinvestment analysis for Biosolution Co.Ltd. For live market cap and broader valuation context, see 086820 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.02x | ₩10.85 Billion | ₩2.16 Billion | ₩1.16 Billion | ▼ -97.7% |
| 2021 | 214.45x | ₩17.86 Billion | ₩83.29 Million | ₩663.15 Million | ▲ +411.1% |
| 2018 | 41.96x | ₩43.06 Billion | ₩1.03 Billion | ₩707.50 Million | — |